{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T05:20:00Z","timestamp":1766380800434,"version":"3.48.0"},"reference-count":4,"publisher":"BMJ","issue":"7141","license":[{"start":{"date-parts":[[1998,5,2]],"date-time":"1998-05-02T00:00:00Z","timestamp":894067200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ"],"published-print":{"date-parts":[[1998,5,2]]},"DOI":"10.1136\/bmj.316.7141.1385a","type":"journal-article","created":{"date-parts":[[2011,10,27]],"date-time":"2011-10-27T19:52:24Z","timestamp":1319745144000},"page":"1385.2","source":"Crossref","is-referenced-by-count":0,"title":["Who should be liable for funding recombinant factor VIII?"],"prefix":"10.1136","volume":"316","author":[{"given":"Richard G","family":"Richards","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1998,5,2]]},"reference":[{"key":"2025122121171154000_316.7141.1385.a.1","unstructured":"Metters J . Further precautionary measures on blood products announced. Public Health Link Cascade Feb 1998."},{"key":"2025122121171154000_316.7141.1385.a.2","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1136\/bmj.316.7133.717","article-title":"Blood transfusion risk: protecting against the unknown","volume":"316","author":"Barbara","year":"1998","journal-title":"BMJ"},{"key":"2025122121171154000_316.7141.1385.a.3","unstructured":"Green C Akehurst RL . Recombinant factor VIII versus plasma derived factor VIII in the management of haemophilia A: an examination of the costs and consequences. Sheffield: Trent Institute for Health Services Research, Universities of Leicester, Nottingham, and Sheffield 1997(Guidance notes for purchasers 97\/04.)"},{"key":"2025122121171154000_316.7141.1385.a.4","unstructured":"Department of Health . Communicating about risks to public health; pointers to good practice. London: DoH, 1997."}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.316.7141.1385a","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.316.7141.1385a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T05:17:16Z","timestamp":1766380636000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.316.7141.1385a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,5,2]]},"references-count":4,"journal-issue":{"issue":"7141","published-online":{"date-parts":[[1998,5,2]]},"published-print":{"date-parts":[[1998,5,2]]}},"alternative-id":["10.1136\/bmj.316.7141.1385a"],"URL":"https:\/\/doi.org\/10.1136\/bmj.316.7141.1385a","relation":{},"ISSN":["0959-8138","1468-5833"],"issn-type":[{"type":"print","value":"0959-8138"},{"type":"electronic","value":"1468-5833"}],"subject":[],"published":{"date-parts":[[1998,5,2]]}}}